Abstract: With the substantive development governing the country by law and administration by law in China,the awareness of citizens has been increasingly enhanced and their awareness of interest protection has been extended from the private interest to the public interest.Recently,a great number of accidents concerning drug safety took place in China and traditional ligation modes are not adequate to meet the demand of public interest protection.To avoid the abuse and inaction of administrative power,the establishment of a public administrative litigation system for pharmaceutical control in China has become inevitable.In view of this development,on the basis amendment of administrative litigation law,we examined the public administrative litigation system for pharmaceutical control and proposed some suggestions concerning the qualification recognition of plaintiff,system modes,burden of proof,rewards and punishment and other issues.

Key words: public interest, pharmaceutical control, public administrative litigation